Catalent Opens cGMP Facility in Japan
The company opened a 200,000-square-foot facility in Kakegawa, Japan to serve the needs of domestic and global clinical trial sponsors.
On June 6, 2016, Catalent Pharma Solutions opened a cGMP facility on its campus in Kakegawa, Japan, the company said in a press announcement. The site will serve the needs of both domestic and global clinical trial sponsors with services including secondary packaging and labeling, clinical storage, distribution, and project management and clinical supply management.
Catalent has additional clinical supply facilities in the United States, United Kingdom, Germany, Singapore, and China, and an extended network of more than 50 audited depots. In the past three years, Catalent has made more than $10 million in capital investments with additional personnel to expand its overall Asia-Pacific footprint.
Source: Catalent
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
